News & Events
Want the latest updates delivered to your inbox?
Subscribe to our newsletter.
RGCC Investigates Potential Treatments and Tests for COVID-19
As the world tries to cope with the rise in cases of covid-19 during the coronavirus pandemic, drug companies…
New test could spot early signs of prostate cancer
Researchers have used genetic testing to detect the very early changes that occur in the tumours of men with…
Study shows genetic changes can occur years before diagnosis
A study suggests the genetic changes that cause cancers can happen years or even decades before the disease is…
Circulating tumour DNA tests predictive in pancreatic cancer
Emerging evidence supports the use of circulating tumour DNA (ctDNA) testing as a tool to predict cancer recurrence.
Liquid biopsy potential to guide colorectal cancer treatment
Liquid biopsies are likely to play an increasing role in identifying which patients with colorectal cancer are most likely…
Top prize in the international iGEM Synthetic Biology competition 2019
We are happy to announce that we supported the iGem Thessaloniki team, which won the top prize in the…
Liquid biopsy option for advanced lung cancer patients
Liquid biopsy tests could be an option for patients with a form of lung cancer, according to the early…
IX Hyperthermie Kongress Berlin
Berlin
Earlier this month Dr Ioannis Papasotiriou attended the IX Hyperthermie Kongress Berlin. The aim of the event is to…
Thessaloniki International Exhibition
Thessaloniki, Greece
Taking place every September, Thessaloniki International Fair is a leading B2B, B2C and B2G event. RGCC attended this…
Success in Switzerland at the 2019 RGCC Gathering
Unterageri, Switzerland
RGCC held its 2019 gathering in Switzerland from 19-20 July, 2019, with staff, collaborators and branch officers from around…